An Artificial Intelligence Accelerated Virtual Screening Platform for Drug Discovery

An artificial intelligence accelerated virtual screening platform for drug discovery

Structure-based virtual screening is a key tool in early drug discovery, with growing interest in the screening of multi-billion chemical compound libraries. However, the success of virtual screening crucially depends on the accuracy of the binding pose and binding affinity predicted by computational docking. Here we develop a highly accurate structure-based virtual screen method, RosettaVS, for predicting docking poses and binding affinities. O…

AI in Drug Discovery Market Dazzling Worldwide | Major Giants Atomwise, AWS, BenevolentAI

HTF Market Insights just released the Global AI in Drug Discovery Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study’s segmentation by important regions. The market is currently expanding its reach.   𝐌𝐚𝐣𝐨𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 AI in Drug Dis…

John Snow Labs Acquires WiseCube to Bolster AI-Powered Biomedical Knowledge and Drug Discovery

What You Should Know:  – John Snow Labs, the AI for healthcare company announced its acquisition of WiseCube, a pioneer in biomedical knowledge graphs and AI-powered literature analysis. Financial details of the acquisition were not disclosed.  – The strategic move is set to significantly enhance John Snow Labs’ mission to deliver responsible, accurate, and explainable healthcare AI solutions by integrating WiseCube’s billion-scale knowledge pla…